Axiocairn · Data date: . Method: Descriptive comparison of the dated observations shown in this report; historical observations do not establish future outcomes.
Summary
Model simulation states do not establish actual holdings or fills; every figure is taken directly from each model's data for the day.
Research limitations: 10Y and OAS are 2026-10-29, the 10Y-2Y spread is 2026-10-30, and as_of for equity, sector and volatility data is not provided, VIX whether it falls on the same day as the stock price remains to be verified; ISM release date 11-02 or 11-03 remains to be verified, PMI 54.5 and 57.6 are forecast, and GDPNow 3.2% has no date; CPI has index points only (336.298,2026-09);year-over-year rates, the Fed target range, historical valuation percentiles, earnings expectations, positioning, volume and pre/post-event rate data are not provided, so crowding cannot be judged; credit has only 3 series, uses the current version, and the version published at the time was not reconstructed.
Since the last report Baseline: 2026-11-06 close | Observation date 2026-11-06 → 2026-11-09 close | Observation date 2026-11-09 Model Change HOT Sector Rotation No additions; no endings; next-day start JETS; next-day end CURE. SnapBack Mean Reversion No additions; no endings. BIO Biotech Swing No additions; no endings; new markers KYMR, BIIB, MTD, IDXX, RPRX, TMO. Spread oversold rebound spread No additions; no endings. LC leader capture No additions; no endings.
2026-11-09 ET
Model simulation states do not establish actual holdings or fills; every figure is taken directly from each model's data for the day.
Report date2026-11-09
Reading route
Since the last report
Baseline: 2026-11-06 close | Observation date 2026-11-06 → 2026-11-09 close | Observation date 2026-11-09
ModelChange
HOT Sector Rotation
No additions; no endings; next-day start JETS; next-day end CURE.
SnapBack Mean Reversion
No additions; no endings.
BIO Biotech Swing
No additions; no endings; new markers KYMR, BIIB, MTD, IDXX, RPRX, TMO.
Market Backdrop · As of last Friday's closeWeekly driver 🔻 equal-weight leadership (breadth-drivenmarket) · SPY 5d -0.6% vs equal-weight+0.8% (gap -1.4pp)Large-cap proxy QQQ−SPY 5d -1.4pp50DMA sector/industry ETF sample7/11
Research limitations: 10Y and OAS are 2026-10-29, the 10Y-2Y spread is 2026-10-30, and as_of for equity, sector and volatility data is not provided, VIX whether it falls on the same day as the stock price remains to be verified; ISM release date 11-02 or 11-03 remains to be verified, PMI 54.5 and 57.6 are forecast, and GDPNow 3.2% has no date; CPI has index points only (336.298,2026-09);year-over-year rates, the Fed target range, historical valuation percentiles, earnings expectations, positioning, volume and pre/post-event rate data are not provided, so crowding cannot be judged; credit has only 3 series, uses the current version, and the version published at the time was not reconstructed.
Research source:Weekly view · 2026-11-02
Observation date: 2026-11-09
ItemReading
NAV
99.51
This month
▲ +1.3%
Year to date
▲ +163.6%
SPY
752.95
SPY SMA50
764.86
SPY SMA200
727.99
Breadth
45%
VIX
19.89
Average model elapsed days
11.00
Latest quote
After-hours
Quote as of ET
17:40
Symbols quoted
5 / 6
Simulated positions
InstrumentSectorHeat rankModel start dateModel start priceLatest close (as of 2026-11-09)Historical price changeModel upper boundModel upper-bound typevs SMA50Model continuation
CURE
XLV
6
2026-10-30
172.79
176.17
▲ +2.0%
241.90
Principal Recovery
▲ +8.5%
No
NAIL
ITB
2
2026-11-03
36.50
39.43
▲ +8.0%
51.10
Principal Recovery
▲ +11.1%
Yes
Latest-quote context (context only; model markers unchanged)
InstrumentTypeReference closeAfter-hours (as of 17:40 ET)Quote time ETvs referenceStart or triggervs start or triggerNearest model levelvs levelCrossing hint
CURE
Model position
176.17
—
—
—
—
—
—
—
No extended-hours trade
NAIL
Model position
39.43
39.42
17:14
▼ -0.0%
36.50
▲ +8.0%
51.10
▼ -22.9%
Not crossed
JETS
Next-session model start
30.21
30.20
16:50
▼ -0.0%
—
—
—
—
Not crossed
GDX
Coil
91.40
91.50
17:25
▲ +0.1%
91.40
▲ +0.1%
—
—
After-hours quote above the trigger; judged on the close per the rule
GLD
Coil
379.51
379.29
17:21
▼ -0.1%
382.71
▼ -0.9%
—
—
Below trigger
KWEB
Coil
24.30
24.37
17:29
▲ +0.3%
24.88
▼ -2.1%
—
—
Below trigger
Next-day model end records
InstrumentSectorReasonLatest close (as of 2026-11-09)Historical price change
CURE
XLV
Rank 6 outside top 4
176.17
▲ +2.0%
Next-day model start records
InstrumentSectorHeat rankReference price
JETS
JETS
1
30.21
Sector heat ranking
RankSectorInstrumentHeatGateIn model recordvs SMA50
InstrumentLegModel start dateModel start priceLatest close (as of 2026-11-09)Historical price changeModel elapsed daysDays leftModel end lineModel end levelTo model end lineNext-day model end marker
FTNT
A
2026-11-02
133.80
122.47
▼ -8.5%
6
14
SMA10 target
138.18
▼ -11.4%
No
VLO
A
2026-10-28
390.33
356.86
▼ -8.6%
9
11
SMA10 target
374.90
▼ -4.8%
No
ZBRA
A
2026-11-02
368.25
326.71
▼ -11.3%
6
14
SMA10 target
349.85
▼ -6.6%
No
MPC
A
2026-10-28
441.85
389.79
▼ -11.8%
9
11
SMA10 target
414.42
▼ -5.9%
No
TMO
B
2026-09-17
654.57
721.63
▲ +10.2%
38
—
Don10 model end line
661.60
▲ +9.1%
No
HUM
B
2026-10-12
435.99
423.32
▼ -2.9%
21
—
Don10 model end line
399.35
▲ +6.0%
No
Latest-quote context (context only; model markers unchanged)
InstrumentTypeReference closeAfter-hours (as of 17:40 ET)Quote time ETvs referenceStart or triggervs start or triggerNearest model levelvs levelCrossing hint
FTNT
Model position
122.47
122.47
16:52
– +0.0%
133.80
▼ -8.5%
138.18
▼ -11.4%
Not crossed
VLO
Model position
356.86
355.87
16:45
▼ -0.3%
390.33
▼ -8.8%
374.90
▼ -5.1%
Not crossed
ZBRA
Model position
326.71
—
—
—
—
—
—
—
No extended-hours trade
MPC
Model position
389.79
389.88
16:44
▲ +0.0%
441.85
▼ -11.8%
414.42
▼ -5.9%
Not crossed
TMO
Model position
721.63
—
—
—
—
—
—
—
No extended-hours trade
HUM
Model position
423.32
423.22
16:48
▼ -0.0%
435.99
▼ -2.9%
399.35
▲ +6.0%
Not crossed
PSX
Queued
253.01
—
—
—
—
—
—
—
No extended-hours trade
Model markers
InstrumentLegReference priceRS percentileResidual zModel queueLeg A target lineLeg B model end line
InstrumentModel start dateModel start priceLatest close (as of 2026-11-09)Historical price changeModel upper boundSMA50Consecutive days below SMA50Model half closed
CRL
2026-08-05
260.98
353.11
▲ +35.3%
365.37
306.83
0
Yes
EXEL
2026-10-30
69.46
71.74
▲ +3.3%
97.24
61.27
0
No
MRNA
2026-10-09
225.22
269.00
▲ +19.4%
315.31
194.47
0
No
Latest-quote context (context only; model markers unchanged)
InstrumentTypeReference closeAfter-hours (as of 17:40 ET)Quote time ETvs referenceStart or triggervs start or triggerNearest model levelvs levelCrossing hint
CRL
Model position
353.11
353.34
16:52
▲ +0.1%
260.98
▲ +35.4%
365.37
▼ -3.3%
Not crossed
EXEL
Model position
71.74
—
—
—
—
—
—
—
No extended-hours trade
MRNA
Model position
269.00
271.64
17:32
▲ +1.0%
225.22
▲ +20.6%
315.31
▼ -13.9%
Not crossed
KYMR
Next-session model start
138.86
138.86
16:44
– +0.0%
—
—
—
—
Not crossed
BIIB
Next-session model start
254.87
—
—
—
—
—
—
—
No extended-hours trade
MTD
Next-session model start
1,761.07
—
—
—
—
—
—
—
No extended-hours trade
IDXX
Next-session model start
706.65
—
—
—
—
—
—
—
No extended-hours trade
RPRX
Next-session model start
68.77
68.11
17:24
▼ -1.0%
—
—
—
—
Not crossed
TMO
Next-session model start
721.63
—
—
—
—
—
—
—
No extended-hours trade
Model markers
InstrumentReference priceRS percentile
KYMR
138.86
93%
BIIB
254.87
88%
MTD
1,761.07
87%
IDXX
706.65
85%
RPRX
68.77
84%
TMO
721.63
83%
Recent model records
InstrumentModel startModel endModel start priceModel end priceHistorical price changeReason
HUM
2026-05-18
2026-08-05
305.59
363.82
▲ +18.9%
Model trend close
CVS
2026-07-16
2026-08-06
105.20
95.54
▼ -9.3%
Model trend close
LQDA
2026-06-09
2026-08-14
64.07
74.44
▲ +16.1%
Model trend close after half
RGEN
2026-08-17
2026-10-08
169.21
163.84
▼ -3.3%
Model trend close
IOVA
2026-08-06
2026-10-30
6.22
8.48
▲ +36.3%
Model trend close after half
Catalyst calendar
InstrumentDateTypeNote
BIIB
2026-12-01
P3 completion window
A Study to Learn More About the Effects and Safety of Felzar
EXEL
2026-12-15
P3 completion window
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Adv
IONS
2026-12-15
P3 completion window
A Study to Assess the Long-Term Safety and Efficacy of Donid
AXSM
2026-12-15
P3 completion window
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and No
AXSM
2026-12-15
P3 completion window
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Ea
MDGL
2026-12-15
P3 completion window
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clin
KRYS
2026-12-15
P3 completion window
A Study Comparing KB803 and Matched Placebo in Patients With
INCY
2026-12-26
P3 completion window
A Study to Evaluate the Long-Term Safety and Efficacy of Pov
Research report for general information. Includes model outputs. Not personalized, not investment advice, and not a recommendation to buy or sell. We do not manage accounts. Data as of 2026-11-09. No performance is guaranteed.
Historical simulation, not live trading. Not a recommendation to buy or sell.